Literature DB >> 34158614

Default mode network dissociation linking cerebral beta amyloid retention and depression in cognitively normal older adults.

Sheng-Min Wang1, Nak-Young Kim2, Yoo Hyun Um3, Dong Woo Kang4, Hae-Ran Na1, Chang Uk Lee4, Hyun Kook Lim5.   

Abstract

Cerebral beta amyloid (Aβ) deposition and late-life depression (LLD) are known to be associated with the trajectory of Alzheimer's disease (AD). However, their neurobiological link is not clear. Previous studies showed aberrant functional connectivity (FC) changes in the default mode network (DMN) in early Aβ deposition and LLD, but its mediating role has not been elucidated. This study was performed to investigate the distinctive association pattern of DMN FC linking LLD and Aβ retention in cognitively normal older adults. A total of 235 cognitively normal older adults with (n = 118) and without depression (n = 117) underwent resting-state functional magnetic resonance imaging and 18F-flutemetamol positron emission tomography to investigate the associations between Aβ burden, depression, and DMN FC. Independent component analysis showed increased anterior DMN FC and decreased posterior DMN FC in the depression group compared with the no depression group. Global cerebral Aβ retention was positively correlated with anterior and negatively correlated with posterior DMN FC. Anterior DMN FC was positively correlated with severity of depression, whereas posterior DMN FC was negatively correlated with cognitive function. In addition, the effects of global cerebral Aβ retention on severity of depression were mediated by subgenual anterior cingulate FC. Our results of anterior and posterior DMN FC dissociation pattern may be pivotal in linking cerebral Aβ pathology and LLD in the course of AD progression. Further longitudinal studies are needed to confirm the causal relationships between cerebral Aβ retention and LLD.
© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34158614      PMCID: PMC8505502          DOI: 10.1038/s41386-021-01072-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  52 in total

Review 1.  Depression and the risk for dementia.

Authors:  Lars Vedel Kessing
Journal:  Curr Opin Psychiatry       Date:  2012-11       Impact factor: 4.741

Review 2.  Depression and risk of developing dementia.

Authors:  Amy L Byers; Kristine Yaffe
Journal:  Nat Rev Neurol       Date:  2011-05-03       Impact factor: 42.937

3.  Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.

Authors:  Nunzio Pomara; Davide Bruno; Antero S Sarreal; Raymundo T Hernando; Jay Nierenberg; Eva Petkova; John J Sidtis; Thomas M Wisniewski; Pankaj D Mehta; Domenico Pratico; Henrik Zetterberg; Kaj Blennow
Journal:  Am J Psychiatry       Date:  2012-05       Impact factor: 18.112

Review 4.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

Authors:  R M Sapolsky
Journal:  Arch Gen Psychiatry       Date:  2000-10

5.  Beyond memory: a focus on the other neuropsychiatric symptoms of dementia.

Authors:  Matthew E Peters; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2015-02       Impact factor: 4.105

6.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis.

Authors:  Raymond L Ownby; Elizabeth Crocco; Amarilis Acevedo; Vineeth John; David Loewenstein
Journal:  Arch Gen Psychiatry       Date:  2006-05

7.  Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors.

Authors:  Yvette I Sheline; Joseph L Price; S Neil Vaishnavi; Mark A Mintun; Deanna M Barch; Adrian A Epstein; Consuelo H Wilkins; Abraham Z Snyder; Lars Couture; Kenneth Schechtman; Robert C McKinstry
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

8.  Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.

Authors:  Wei Qiao Qiu; Haihao Zhu; Michael Dean; Zhiheng Liu; Linh Vu; Guanguang Fan; Huajie Li; Mkaya Mwamburi; David C Steffens; Rhoda Au
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-06       Impact factor: 3.485

9.  High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.

Authors:  Fumihiko Yasuno; Hiroaki Kazui; Naomi Morita; Katsufumi Kajimoto; Masafumi Ihara; Akihiko Taguchi; Akihide Yamamoto; Kiwamu Matsuoka; Jun Kosaka; Takashi Kudo; Hidehiro Iida; Toshifumi Kishimoto; Kazuyuki Nagatsuka
Journal:  Int J Geriatr Psychiatry       Date:  2016-01-14       Impact factor: 3.485

Review 10.  Pathways linking late-life depression to persistent cognitive impairment and dementia.

Authors:  Meryl A Butters; Jeffrey B Young; Oscar Lopez; Howard J Aizenstein; Benoit H Mulsant; Charles F Reynolds; Steven T DeKosky; James T Becker
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more
  3 in total

1.  Beneficial Effect of High-Frequency Repetitive Transcranial Magnetic Stimulation for the Verbal Memory and Default Mode Network in Healthy Older Adults.

Authors:  Dong Cui; Jingna Jin; Weifang Cao; He Wang; Xin Wang; Ying Li; Tianjun Liu; Tao Yin; Zhipeng Liu
Journal:  Front Aging Neurosci       Date:  2022-05-04       Impact factor: 5.750

Review 2.  Pathomechanisms of Vascular Depression in Older Adults.

Authors:  Kurt A Jellinger
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

3.  Intrinsic Brain Activity Alterations in Patients With Mild Cognitive Impairment-to-Normal Reversion: A Resting-State Functional Magnetic Resonance Imaging Study From Voxel to Whole-Brain Level.

Authors:  Qili Hu; Qianqian Wang; Yunfei Li; Zhou Xie; Xiaomei Lin; Guofeng Huang; LinLin Zhan; Xize Jia; Xiaohu Zhao
Journal:  Front Aging Neurosci       Date:  2022-01-17       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.